chr7-81974555-GA-G
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2
The NM_000722.4(CACNA2D1):c.1956-4delT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000556 in 1,344,872 control chromosomes in the GnomAD database, including 4 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0025 ( 2 hom., cov: 30)
Exomes 𝑓: 0.00032 ( 2 hom. )
Consequence
CACNA2D1
NM_000722.4 splice_region, intron
NM_000722.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.195
Genes affected
CACNA2D1 (HGNC:1399): (calcium voltage-gated channel auxiliary subunit alpha2delta 1) The preproprotein encoded by this gene is cleaved into multiple chains that comprise the alpha-2 and delta subunits of the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. Mutations in this gene can cause cardiac deficiencies, including Brugada syndrome and short QT syndrome. Alternate splicing results in multiple transcript variants, some of which may lack the delta subunit portion. [provided by RefSeq, Nov 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP6
Variant 7-81974555-GA-G is Benign according to our data. Variant chr7-81974555-GA-G is described in ClinVar as [Likely_benign]. Clinvar id is 416578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-81974555-GA-G is described in Lovd as [Benign].
BS2
High AC in GnomAd4 at 367 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA2D1 | NM_000722.4 | c.1956-4delT | splice_region_variant, intron_variant | ENST00000356860.8 | NP_000713.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA2D1 | ENST00000356860.8 | c.1956-4delT | splice_region_variant, intron_variant | 1 | NM_000722.4 | ENSP00000349320.3 | ||||
CACNA2D1 | ENST00000443883.2 | c.1992-4delT | splice_region_variant, intron_variant | 5 | ENSP00000409374.2 | |||||
CACNA2D1 | ENST00000705962.1 | c.1836-4delT | splice_region_variant, intron_variant | ENSP00000516190.1 | ||||||
CACNA2D1 | ENST00000705961.1 | c.1722-4delT | splice_region_variant, intron_variant | ENSP00000516189.1 |
Frequencies
GnomAD3 genomes AF: 0.00247 AC: 364AN: 147524Hom.: 2 Cov.: 30
GnomAD3 genomes
AF:
AC:
364
AN:
147524
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000814 AC: 158AN: 194206Hom.: 1 AF XY: 0.000589 AC XY: 62AN XY: 105240
GnomAD3 exomes
AF:
AC:
158
AN:
194206
Hom.:
AF XY:
AC XY:
62
AN XY:
105240
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000318 AC: 381AN: 1197266Hom.: 2 Cov.: 18 AF XY: 0.000282 AC XY: 171AN XY: 605532
GnomAD4 exome
AF:
AC:
381
AN:
1197266
Hom.:
Cov.:
18
AF XY:
AC XY:
171
AN XY:
605532
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00249 AC: 367AN: 147606Hom.: 2 Cov.: 30 AF XY: 0.00202 AC XY: 145AN XY: 71768
GnomAD4 genome
AF:
AC:
367
AN:
147606
Hom.:
Cov.:
30
AF XY:
AC XY:
145
AN XY:
71768
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 23, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | May 14, 2018 | - - |
Brugada syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 27, 2024 | - - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 08, 2017 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at